What are the clinical forms, presentation, and recommended antibiotic treatment and prophylaxis for plague (Yersinia pestis infection)?

Plague (Yersinia pestis): forms, presentation, and antibiotic treatment/prophylaxis

Treat suspected plague immediately with a first-line fluoroquinolone (ciprofloxacin preferred) or an aminoglycoside, with doxycycline as first-line for bubonic/pharyngeal disease, for 10–14 days; give ciprofloxacin or doxycycline for post-exposure prophylaxis; in suspected engineered resistance (bioterrorism), start two drug classes until susceptibilities return to reduce mortality and preserve quality of life 1.

Clinical forms and presentation (mortality/QOL implications)

• Bubonic (most common): sudden fever/chills/malaise, painful regional “bubo”; can progress to septicemia/pneumonia if delayed—untreated CFR ~66%; treated ~13% 1.
• Pneumonic (primary via inhalation; secondary via spread): 1–3 days incubation, fever, dyspnea, rapidly to bloody sputum, respiratory failure, sepsis; almost universally fatal if untreated; urgent therapy saves lives 1.
• Septicemic: fever ± GI symptoms (abdominal pain, N/V/D) without obvious focus; higher fatality than bubonic; often diagnostic delays—act fast to prevent death 1.
• Meningeal (complication of delayed/inadequate treatment): fever, neck stiffness, confusion; CSF neutrophilia with Gram-negative bacilli 1.
• Pharyngeal: sore throat with cervical nodes after oropharyngeal contamination; typically milder but can progress if untreated 1.

First-line antimicrobial treatment (10–14 days total) to reduce mortality

• General principles

  • Start promptly; choose route by severity (IV for severe/unstable; oral acceptable if stable and tolerating) and step down when improved 1.
  • FDA-approved options: ciprofloxacin, levofloxacin, moxifloxacin, doxycycline; streptomycin approved; gentamicin effective though not FDA-labeled 1.
  • In suspected engineered resistance (bioterrorism), begin two distinct classes (e.g., ciprofloxacin + gentamicin) until susceptibilities available to ensure at least one active agent 1.

• Pneumonic or Septicemic plague (highest lethality; prioritize rapid bactericidal therapy)

  • Preferred: fluoroquinolone (ciprofloxacin) OR aminoglycoside (gentamicin or streptomycin) as initial monotherapy; consider combo of two classes if resistance risk or critical illness 1.
  • Duration: 10–14 days; extend if persistent fever/concerns 1.

• Bubonic or Pharyngeal plague

  • First-line: doxycycline (excellent outcomes in bubonic; safe short-course even in young children when life-threatening) OR a fluoroquinolone (ciprofloxacin) OR an aminoglycoside 1.
  • Note: Buboes are acidic; theoretical aminoglycoside attenuation, but clinical efficacy remains acceptable; drainage only if suppurative and after antibiotics started 1.
  • Duration: 10–14 days 1.

• Meningeal plague

  • Use agents with CNS penetration; follow guideline tables (e.g., fluoroquinolone-based regimens or chloramphenicol alternatives if indicated) and treat ≥14 days if meningeal involvement persists 1.

• Special populations/nuances

  • Children: Doxycycline short courses (≤21 days) do not cause tooth staining; justified for life-threatening infections; moxifloxacin is alternative, not first-line, due to QT risk and lack of pediatric approval 1.
  • Pregnancy/breastfeeding and neonates: Refer to guideline dosing tables; fluoroquinolones and aminoglycosides included with risk–benefit tailored to severity; ciprofloxacin listed as preferred first-line overall by CDC 2021 update 1.
  • Step-down: Transition IV→oral once clinically improved and tolerating PO; total course unchanged 1.

Post-exposure and pre-exposure prophylaxis (to prevent progression and deaths)

• Indications: Determined by public health risk assessment after known/likely exposure (e.g., close contact with pneumonic case, lab/bioterrorism exposure, flea exposure in outbreaks) 1.
• Preferred agents (adults and children when appropriate):
  • Ciprofloxacin OR doxycycline; levofloxacin/moxifloxacin are acceptable alternatives; TMP-SMX is an alternative option per 2021 update 1.
• Duration: As directed by public health authorities based on exposure window; CDC includes both pre-exposure and post-exposure options in 2021 guidance 1.

Practical, outcome-focused algorithm

1. Suspect plague based on syndrome/exposure; isolate pneumonic cases with droplet precautions early to reduce transmission deaths 1.
2. If pneumonic or septicemic OR severe illness: start IV ciprofloxacin OR gentamicin/streptomycin immediately; consider dual-class therapy if bioterrorism/engineered resistance suspected; treat 10–14 days 1.
3. If bubonic/pharyngeal and stable: start doxycycline (first-line) or ciprofloxacin; treat 10–14 days; monitor for progression; manage buboes conservatively unless fluctuant 1.
4. If meningeal signs: select regimen with CNS penetration per guideline; extend duration based on response 1.
5. Provide prophylaxis (ciprofloxacin or doxycycline) to exposed contacts per public health directives to prevent secondary cases and deaths 1.
6. In suspected engineered resistance or outbreak: obtain cultures/PCR; begin two drug classes; narrow when susceptibilities return; coordinate with public health 1.

Strength of evidence and pitfalls

• Most definitive, recent, high-quality source: 2021 CDC MMWR guideline—elevates ciprofloxacin to first-line for treatment and prophylaxis; adds levofloxacin/moxifloxacin options; includes TMP-SMX as prophylaxis alternative; provides pediatric/neonatal guidance; and dual-class approach in bioterrorism—these drive the recommendations above 1.
• Pitfalls to avoid:
  • Delayed therapy in pneumonic plague—mortality rises steeply; treat immediately on suspicion 1.
  • Under-dosing or too-short therapy—complete 10–14 days; extend if not afebrile/clinically improved 1.
  • Overlooking septicemic presentations mimicking GI illness—maintain high suspicion to prevent fatal progression 1.
  • Assuming resistance is common—natural resistance is rare, but be vigilant for engineered resistance in bioterrorism; start two classes if suspected 1.
  • Pediatric concerns about doxycycline tooth effects—short courses are safe and lifesaving in plague 1.